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CYLD encodes a tumor suppressor that is
mutated in familial cylindromatosis. Despite
biochemical and cell culture studies, the physio-
logical functions ofCYLD in animal development
and tumorigenesis remain poorly understood.
To address these questions, we generated
Drosophila CYLD (dCYLD) mutant and trans-
genic flies expressing wild-type and mutant
dCYLD proteins. Here we show that dCYLD is
essential for JNK-dependent oxidative stress
resistance and normal lifespan. Furthermore,
dCYLD regulates TNF-induced JNK activation
and cell death through dTRAF2, which acts
downstream of the TNF receptor Wengen and
upstream of the JNKK kinase dTAK1. We show
that dCYLD encodes a deubiquitinating enzyme
that deubiquitinates dTRAF2 and prevents
dTRAF2 from ubiquitin-mediated proteolytic
degradation. These data provide a molecular
mechanism for the tumor suppressor function
of this evolutionary conserved molecule by indi-
cating that dCYLD plays a critical role in modu-
lating TNF-JNK-mediated cell death.
INTRODUCTION
Mutations in the tumor suppressor CYLD have been asso-
ciated with familial cylindromatosis (Brooke-Spiegler
syndrome), an autosomal dominant inherited disease
characterized by the development of multiple skin
appendage tumors such as cylindroma, trichoepithe-
lioma, and spiradenoma (Bignell et al., 2000; Lee et al.,
2005). The physiological functions of CYLD in animal
development and tumorigenesis remain largely unclear.
Recent studies have indicated that CYLD encodes a deu-
biquitinating enzyme that, by removing K46- or K63-linked
polyubiquitin chains (or both) from its target, modulates
multiple signaling pathways in immune and epithelial cells.
In vitro studies have suggested that CYLD negatively reg-
ulates the p65/p50 NF-kB pathway by removing K63-446 Developmental Cell 13, 446–454, September 2007 ª2007linked polyubiquitin chains from TRAF2/6 (Brummelkamp
et al., 2003; Kovalenko et al., 2003; Massoumi et al., 2006;
Trompouki et al., 2003). Hence, it was proposed that loss
of CYLD would result in hyperactivation of p65/p50 NF-kB
and survival of tumor cells. However, in contrast to this
hypothesis, ectopic activation of this signaling in mouse
epithelial tissue results in epidermal hypoplasia and
growth inhibition rather than epidermal hyperplasia (Seitz
et al., 1998). Another study has suggested that CYLD deu-
biquitinates K63-linked polyubiquitination from Bcl-3 and
inhibits p50/Bcl-3- or p52/Bcl-3-depedent proliferation
in mouse keratinocytes (Massoumi et al., 2006). Recently,
it has been shown that CYLD deubiquitinates both K48-
and K63-linked polyubiquitin chains from Lck and regu-
lates TCR signaling in thymocytes (Reiley et al., 2006).
Thus, depending on the specific cellular context, CYLD
may execute its functions via two different molecular
mechanisms: the K48-linked, polyubiquitination-medi-
ated, proteasome-dependent protein degradation and
K63-linked, polyubiquitination-mediated endocytosis
and signal transduction.
The c-Jun N-terminal kinase (JNK) signaling pathway
has been conserved from flies to humans and plays
a wide range of roles from stress response to apoptosis
(Davis, 2000). Interestingly, mice deficient for jnk1 show
enhancedskin tumordevelopment (Sheetal., 2002), aphe-
notype similar to cyld mutants (Massoumi et al., 2006).
However, the role of CYLD in JNK signaling has remained
controversial, and the mechanism unknown (Reiley et al.,
2004, 2006; Zhang et al., 2006). In Drosophila, the Tumor
Necrosis Factor (TNF) orthlog Eiger (Egr) triggers the cell
death pathway through its receptor Wengen (Wgn), which
in turn activates the conserved JNK cascade, the JNKK
kinase dTAK1, the JNK kinase Hep, and Drosophila JNK
Bsk (Igaki et al., 2002; Moreno et al., 2002).
Drosophila has been used as a powerful model organ-
ism for the genetic dissection of conserved signaling path-
ways in development. Given that CYLD is conserved from
invertebrates to mammals (Bignell et al., 2000), we char-
acterized the in vivo functions of CYLD in Drosophila by
generating dCYLD mutants and transgenic animals
expressing wild-type or mutant dCYLD proteins. Our
genetic and biochemical analyses indicated that a major
function of dCYLD is regulating JNK-mediated cell death
through deubiquitinating dTRAF2.Elsevier Inc.
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dCYLD Regulates JNK SignalingRESULTS AND DISCUSSION
Loss of dCYLD Compromises JNK-Dependent
Oxidative Stress Resistance and Lifespan
The Drosophila genome encodes a single CYLD ortholog,
dCYLD (CG5603) (Adams et al., 2000). To obtain the
dCYLD mutant, we generated a 5 kb genomic deletion
bymale recombination (Chen et al., 1998). This deficiency,
termed dCYLDmr4, deletes the entire upstream region and
the first 57 amino acids of dCYLD, as well as the coding
regions of two adjacent genes, CG5395 and CG13138
(Figure 1A), and thus represents null mutations for these
three genes. To obtain flies only mutant for dCYLD,
a transgene, pLX107, containing the genomic region for
CG5395 and CG13138, was introduced into the fly
genome and was able to rescue the lethality of homozy-
gous dCYLDmr4 flies (Figure 1A). The rescued flies, which
represent null mutants only for dCYLD, were viable and
fertile, with no obvious morphological abnormalities
(data not shown), suggesting that dCYLD is dispensable
for viability and fertility. RT-PCR experiments confirmed
that no dCYLD transcripts were produced in homozygous
dCYLDmr4 pLX107 flies, as compared with wild-type
(Figure S1 in the Supplemental Data available with this
article online). However, we found that dCYLDmr4
pLX107 mutant animals were shorter lived than wild-type
or heterozygous dCYLD flies (Figure 1B). This phenotype
could be rescued by adding one copy of dCYLDRes
(Figure 1B), a genomic rescue transgene for dCYLD (Fig-
ure 1A), which confirms that loss of dCYLD is the cause
of this defect. Similarly, other defects associated with
dCYLDmr4 pLX107 are also rescued by the dCYLDRes
transgene (Experimental Procedures). Thus, we refer to
dCYLDmr4 pLX107 as dCYLD mutants from hereon out.
Shortened animal lifespan may result from compro-
mised oxidative stress tolerance (Beckman and Ames,
1998). To examine the oxidative stress resistance,
3-day-old flies were challenged with paraquat for
a prolonged period of time and their survival rates were
measured (Wang et al., 2003). We found that dCYLD
mutants exhibited a significant reduction in survival rate
as compared with wild-type or heterozygous dCYLD flies
after 24 hr (Figure 1C) or 36 hr (Figure S2) of exposure to
paraquat, suggesting dCYLD plays a pivotal role in regu-
lating oxidative stress resistance.
JNK signaling has been reported to play an important
role in regulating oxidative stress resistance and lifespan
inDrosophila (Wang et al., 2003).We found that ubiquitous
expression of Bsk, theDrosophila JNK ortholog, under the
control of tubulin promoter, rescues both lifespan and
oxidative stress resistance defects in dCYLD mutants
(Figures 1D and 1E), suggesting that dCYLD regulates
these two physiological effects through the JNK signaling
pathway.
We have extended our study to other stress conditions
and found that dCYLD mutants are less resistant to dry
starvation (no food and water, Figure S3), a phenotype
that has been associated with reduced JNK activity
(Wang et al., 2003). On the other hand, dCYLD mutantsDevelopmentado not affect animal survival at high and low temperature
conditions (37C and 4C, data not shown).
Loss of dCYLD Suppresses Ectopic Egr-Induced
JNK Activation and Cell Death
To further examine the role of dCYLD in regulating JNK
signaling in animal development, we tested the genetic
interactions between dCYLD andEiger (Egr), theDrosoph-
ila ortholog of TNF that triggers the JNK pathway (Igaki
et al., 2002; Moreno et al., 2002). Ectopic expression of
Egr, under the control of the GMR promoter (GMR > Egr)
and using the Gal4/UAS binary system (Brand and
Perrimon, 1993), induces JNK activation and cell death
in the developing eye that results in vastly reduced adult
eye size (Igaki et al., 2002; Moreno et al., 2002)
(Figure S4B; Figure 2C). The Egr-induced JNK activation
and small-eye phenotype was suppressed modestly by
deleting one copy of dCYLD (Figure 2D and data not
shown) and suppressed soundly by removing both copies
(Figure S4C; Figure 2E). The strong suppression of the Egr
eye phenotype in homozygous dCYLD mutants was
partially reverted by adding one copy of dCYLDRes
(Figure 2F). These results indicate that dCYLD is required
for Egr-triggered JNK activation and cell death.
The Ubiquitin Carboxyl-Terminal Hydrolase
Deubiquitinating Domains Are Necessary
for dCYLD Functions
dCYLD encodes a protein of 640 amino acids, containing
in its N terminal portion a cytoskeleton-associated protein
(CAP) domain that is present in proteins associated with
microtubules and the cytoskeletal network (Riehemann
and Sorg, 1993), two ubiquitin carboxyl-terminal hydro-
lases (UCH) domains that are commonly associated with
deubiquitinating enzyme activity (D’Andrea and Pellman,
1998), and three CXXC zinc-finger (ZF) motifs with poten-
tial protein-protein interaction ability (Giot et al., 2003)
(Figure 2A). To functionally characterize these motifs, we
generated UAS transgenes expressing the wild-type or
three mutant versions of dCYLD that delete the CAP
domain, the two UCH domains, or the three ZF motifs
(Figure 2A). When expressed under the control of the
GMR promoter, neither the full-length nor the dCYLD
mutants displayed any detectable phenotype (Figure 2G
and data not shown). When introduced into the GMR >
Egr; dCYLD/ background, wild-type dCYLD released
the suppression of the Egr eye phenotype (Figure 2H),
confirming that the suppressive effect was due to the
loss of dCYLD functions. In contrast, dCYLDDUCH had
no effect on the suppression of the Egr eye phenotype
(Figure 2J), and dCYLDDCAP could only partially relieve
this suppression (Figure 2I), implying that the UCH
domains are necessary for dCYLD functions and that the
CAP domain is essential for dCYLD to execute its full
activity in vivo. Interestingly, expression of dCYLDDZF
completely abolished the suppression effect (Figure 2K),
suggesting that the ZF motifs are dispensable in dCYLD
regulation of Egr-induced cell death.l Cell 13, 446–454, September 2007 ª2007 Elsevier Inc. 447
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dCYLD Regulates JNK SignalingFigure 1. dCYLD Is Required for JNK-Dependent Oxidative Stress Resistance and Normal Lifespan in Drosophila
(A) Genomic structure of dCYLD locus, dCYLDmr4 mutant, and pLX107 and dCYLDRes transgenes. The intron-exon structure and the open reading
frame (in black) of dCYLD are depicted. The P element l(2)08774 used for male recombination is indicated.
(B) Loss of dCYLD reduces lifespan. dCYLDmutant males (W1118; dCYLDmr4 pLX107) show significant reduction of median and maximal lifespan as
compared with wild-type (W1118) or heterozygous dCYLD (W1118; dCYLDmr4 pLX107/+) males. This reduction was largely rescued by one copy of
dCYLDRes (W1118; dCYLDmr4 pLX107; dCYLDRes/+). Similar results were obtained with females (data not shown). Survival of three independent
cohorts with about 100 flies each was monitored over time. Statistical analysis was performed using the log rank test. Cohort sizes and p values
are as follows: WT, n = 322; dCYLD/+, n = 288; dCYLD, n = 424; dCYLD; dCYLDRes/+, n = 276; p < 0.001.
(C) Loss of dCYLD compromises oxidative stress resistance. Three-day-old flies were fed with 15 mM paraquat in 5% sucrose for twenty-four hours,
and their survival rates were measured. dCYLD mutants show significant reduction in survival rates as compared with wild-type or heterozygous
dCYLD flies. This reduction was strongly rescued by one copy of dCYLDRes. Data are represented as mean ± SD.
(D) The reduced lifespan of dCYLD mutant males (W1118; dCYLDmr4 pLX107) was fully rescued by ubiquitous expression of either Bsk (W1118;
dCYLDmr4 pLX107; tub-Gal4/UAS-Bsk) or full-length dCYLD (W1118; dCYLDmr4 pLX107; tub-Gal4/UAS-dCYLD), but not that of dCYLDDUCH448 Developmental Cell 13, 446–454, September 2007 ª2007 Elsevier Inc.
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dCYLD Regulates JNK SignalingFigure 2. dCYLD Is Required for GMR > Egr-Triggered Cell Death Phenotype
(A) Schematic representation of CYLD, dCYLD, dCYLDDCAP, dCYLDDUCH, and dCYLDDZF proteins.
(B–K) Light micrographs ofDrosophila adult eyes are shown. Compared with wild-type (B,GMR-Gal4/+),GMR > Egr triggers cell death and produces
a small-eye phenotype (C, UAS-Egr/+; GMR-Gal4/+). This phenotype is suppressed partially by deleting one copy (D, UAS-Egr/dCYLDmr4 pLX107;
GMR-Gal4/+) and almost fully by removing both copies (E, UAS-Egr dCYLDmr4/dCYLDmr4 pLX107; GMR-Gal4/+) of endogenous dCYLD gene. The
suppression ofGMR > Egr phenotype in dCYLD homozygous mutants is partially released by adding one copy of dCYLDRes (F, UAS-Egr dCYLDmr4/
dCYLDmr4 pLX107; GMR-Gal4/dCYLDRes) or expressing dCYLDDCAP (I, UAS-Egr dCYLDmr4/dCYLDmr4 pLX107; GMR-Gal4/UAS-dCYLDDCAP),
and is released fully by the expression of dCYLD (H, UAS-Egr dCYLDmr4/dCYLDmr4 pLX107; GMR-Gal4/UAS-dCYLD) or dCYLDDZF (K, UAS-Egr
dCYLDmr4/dCYLDmr4 pLX107; GMR-Gal4/UAS-dCYLDDZF), but not that of dCYLDDUCH (J, UAS-Egr dCYLDmr4/dCYLDmr4 pLX107; GMR-Gal4/
UAS-dCYLDDUCH). Expression of wild-type dCYLD protein in the eye produces no discernible phenotype (G, GMR-Gal4/UAS-dCYLD).Ubiquitous expression of the full-length dCYLD, but not
dCYLDDUCH, rescues both shortened lifespan and hy-
persensitivity to paraquat in dCYLD mutants (Figures 1D
and 1E), which suggests that the deubiquitinating activity
is indispensable for dCYLD to regulate JNK-dependent
oxidative stress resistance and lifespan.DevelopmendTRAF2 Is Required for Ectopic Egr-Induced
Cell Death
TNF receptor-associated factors (TRAFs) are important
adaptor proteins that bind to TNF receptors and relay
TNF signals to the JNK and NF-kB pathways in mammals
(Bradley and Pober, 2001). In Drosophila, Egr signal is(W1118; dCYLDmr4 pLX107; tub-Gal4/UAS-dCYLDDUCH). Similar results were obtained with females (data not shown). Cohort sizes and p values are
as follows: dCYLD, n = 424; dCYLD; tub > Bsk, n = 268; dCYLD; tub > dCYLD, n = 247; dCYLD; tub > dCYLDDUCH, n = 230; p < 0.001.
(E) The compromised oxidative stress resistance of dCYLDmutants was fully rescued by ubiquitous expression of either Bsk or full-length dCYLD, but
not that of dCYLDDUCH. Data are represented as mean ± SD.tal Cell 13, 446–454, September 2007 ª2007 Elsevier Inc. 449
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dCYLD Regulates JNK SignalingFigure 3. dCYLD Regulates Egr-Induced JNK Activation Through dTRAF2
(A–F) dTRAF2 is required for the GMR > Egr-induced cell death phenotype. Light micrographs of Drosophila adult eyes are shown. The GMR > Egr
phenotype (A) is not suppressed by deleting one wild-type copy of dTRAF1 (B, UAS-Egr/dTRAF1EX; GMR-Gal4/+) or by expressing a dTRAF1
RNAi (C, UAS-Egr/UAS-dTRAF1-IR; GMR-Gal4/+), but is suppressed strongly by removing one wild-type copy of dTRAF2 gene (D, dTRAF2EX/+;
UAS-Egr/+; GMR-Gal4/+) and suppressed completely by removing both wild-type copies (E, dTRAF2EX; UAS-Egr/+; GMR-Gal4/+); it is almost
suppressed completely by expressing a dTRAF2 RNAi (F, UAS-Egr/UAS-dTRAF2-IR; GMR-Gal4/+).
(G–L) dCYLD and dTRAF2 are required for Egr-induced JNK activation. X-Gal staining of a puc-LacZ reporter gene in third-instar larval eye discs is
shown. The weak endogenous puc expression is detected after extensive staining (G, GMR-Gal4/pucE69). The puc expression posterior to the MF
is significantly reduced in homozygous dCYLD mutants (H, dCYLDmr4 pLX107; GMR-Gal4/ pucE69), or is reduced by expressing a dTRAF2 RNAi (I,
UAS-dTRAF2-IR/+;GMR-Gal4/ pucE69), while the puc expression in disc edge is not affected (arrows in G–I).GMR > Egr induces puc expression pos-
terior to the MF (J, UAS-Egr/+; GMR-Gal4/pucE69), which is strongly suppressed by the removal of both wild-type copies of dCYLD (K, UAS-Egr
dCYLDmr4/dCYLDmr4 pLX107; GMR-Gal4/ pucE69), or by the expression of a dTRAF2 RNAi (L, UAS-Egr/UAS-dTRAF2-IR; GMR-Gal4/ pucE69). Eye
discs were dissected from third-instar larvae and stained for b-galactosidase activity as described (Xue and Noll, 2002). Staining was performed at
37C for 12 hr (G–I) or at room temperature for 2 hr (J–L).
(M–X) Genetic epistatic analysis of dCYLD and dTRAF2 in the Egr-JNK pathway. (M–R) Light micrographs of Drosophila adult eyes are shown.
Expression of dTAK1 in developing eyes under the control of the sev promoter induces apoptosis and generates rough eyes with a slightly reduced
size (M, sev-Gal4 UAS-dTAK1/+). This phenotype is not suppressed by removing both wild-type copies of dCYLD (N, dCYLDmr4 pLX107; sev-Gal4
UAS-dTAK1/+) or dTRAF2 (O, dTRAF2EX; sev-Gal4 UAS-dTAK1/+), nor by expressing a dTRAF2 RNAi (P, sev-Gal4 UAS-dTAK1/UAS -dTRAF2-IR),450 Developmental Cell 13, 446–454, September 2007 ª2007 Elsevier Inc.
Developmental Cell
dCYLD Regulates JNK Signalingmediated exclusively by the JNK pathway (Igaki et al.,
2002;Moreno et al., 2002). However, the role ofDrosophila
TRAF proteins in Egr-JNK signaling remains unclear. The
Drosophila genome encodes two TRAFs: dTRAF1, the
TRAF2 ortholog; and dTRAF2, the TRAF6 ortholog (Adams
et al., 2000). To determine the role of dTRAF1 and dTRAF2
in Egr-JNK signaling, we checked the effects of loss-of-
function mutations and RNAi-mediated downregulation
of dTRAF1 or dTRAF2 on the Egr eye phenotype (Cha
et al., 2003; Kuranaga et al., 2002). We found that the
Egr-induced small-eye phenotype was not suppressed
by either deletion of one copy of the dTRAF1 gene
(Figure 3B) or coexpression of a dTRAF1RNAi (Figure 3C).
In contrast, the Egr eye phenotype was suppressed
strongly by removing half of the dosage of dTRAF2
(Figure 3D) and suppressed completely by deleting the
dTRAF2 gene (Figure 3E). Consistently, coexpression of
a dTRAF2 RNAi significantly suppressed the Egr eye phe-
notype (Figure 3F). In agreement with our genetic data,
dTRAF2 exhibited a much stronger physical interaction
with Wgn and dTAK1 than dTRAF1 did (Geuking et al.,
2005; Kauppila et al., 2003). Together, the above results
point to dTRAF2, but not dTRAF1, as the adaptor protein
that mediates Egr signaling in Drosophila.
dCYLD and dTRAF2 Are Required for Endogenous
JNK Signaling
To investigate the physiological functions of dCYLD and
dTRAF2 in JNKactivation,wechecked the expressionpat-
tern of puckered (puc) in dCYLD or dTRAF2 mutants. puc
encodes a JNK phosphatase whose expression is posi-
tively regulated by the JNK pathway (Martin-Blanco
et al., 1998), and thus, the puc-LacZ expression of the
pucE69 enhancer-trap allele can be used as a readout of
JNK activity in vivo (Agnes et al., 1999). puc is weakly
expressed in wild-type third-instar eye discs, and can be
detected by prolonged staining (Agnes et al., 1999; Igaki
et al., 2002) (Figure 3G). It has been previously shown
that puc expression posterior to themorphogenetic furrow
(MF) depends on endogenous Egr signaling (Igaki et al.,
2002). We found that such expression patterns were
reduced dramatically in dCYLD mutants (Figure 3H) and
dTRAF2 RNAi animals (Figure 3I). In contrast, puc ex-
pression in the disc margin, which is independent of Egr
signaling (Igaki et al., 2002), was not affected (arrows in
Figure 3G–3I). GMR > Egr strongly activated puc trans-
cription posterior to the MF (Igaki et al., 2002) (Figure 3J).
This ectopic Egr-induced puc expression was largely
blocked by loss of dCYLD (Figure 3K) or by expression of
dTRAF2 RNAi (Figure 3L). Taken together, our ob-
servations indicate that both dCYLD and dTRAF2
are physiologically required by the endogenous JNK
pathway.DevelopmenThe role of CYLD in modulating JNK signaling in mam-
malian cells has remained controversial. Consistent with
our observation, it was reported that JNK activity dimin-
ished in Cyld/ thymocytes (Reiley et al., 2006), which
implies that CYLD is physiologically required for JNK
activation. However, CYLD was also reported to nega-
tively regulate JNK signaling in culture cells (Reiley et al.,
2004) and macrophages (Zhang et al., 2006). Thus,
CYLD could positively or negatively regulate JNK signal-
ing in a cell-type-specific manner.
dCYLD Regulates JNK Signaling Through dTRAF2
To genetically map the epistasis of dCYLD and dTRAF2 in
the Egr-JNK pathway, we examined the genetic interac-
tion between dTAK1 (JNKKK) and dCYLD or dTRAF2 in
the developing eyes. Expression of dTAK1 under the con-
trol of the GMR promoter resulted in pupa lethality (data
not shown), while dTAK1 expression under the control
of the sevenless (sev) promoter (sev > dTAK1) induced ex-
tensive cell death in larval eye discs and gave rise to rough
eyes with a reduced size (Mihaly et al., 2001; Takatsu
et al., 2000) (Figure 3M). Loss of dCYLD (Figure 3N) or
dTRAF2 (Figure 3O), or coexpression of a dTRAF2 RNAi
(Figure 3P), had no effect on the sev > dTAK1 phenotype,
while removal of one copy of hep (JNKK) (Figure 3Q) or
bsk (JNK) (Figure 3R) partially suppressed the sev >
dTAK1 phenotype (Mihaly et al., 2001; Takatsu et al.,
2000), which suggests that dCYLD and dTRAF2 operate
upstream of dTAK1 in the Egr-JNK pathway.
Ectopic Egr expression in the dorsal thorax driven by
the potent pannier-GAL4 driver resulted in pupa lethality
(data not shown). However, when reared at 18C, these
animals survived to adulthood, presumably due to less-
ened Egr expression caused by reduced Gal4 activity,
and produced a small-scutellum phenotype (Figure 3T).
This phenotype could be suppressed by RNAi inactivation
of JNK signaling components, e.g.,wgn, dTRAF2, dTAK1,
hep, or bsk (data not shown), which suggests that the phe-
notype is caused by activation of JNK signaling. Ectopic
expression of dCYLD driven by pannier-GAL4 produced
a similar but weaker phenotype (Figure 3U), which could
be fully suppressed by the coexpression of an RNAi of
dTRAF2 (Figure 3W) and dTAK1 (Figure 3X), but not that
of wgn (Figure 3V). These results indicate that dCYLD
functions downstream of Wgn, but upstream of dTRAF2
and dTAK1, in modulating JNK signaling.
RNAi-mediated downregulation of dTRAF2, but not
dTRAF1, resulted in compromised oxidative stress resis-
tance and shortened lifespan (Figure S5), which suggests
that the role of dTRAF2 in dCYLD-JNK signaling has been
conserved in different physiological contexts.
Previous studies have reported that the Shark tyrosine
kinase and Src42A regulate JNK signaling in epidermalbut is suppressed partially by deleting one copy of hep (Q, hep1/+; sev-Gal4 UAS-dTAK1/+) or bsk (R, bsk1+/; sev-Gal4 UAS-dTAK1/). (S–X) Light mi-
crographs ofDrosophila adult thorax are shown. Comparedwith wild-type (S, pnr-Gal4/+), expression of Egr (T,UAS-Egr/+; pnr-Gal4/+) or dCYLD (U,
UAS-dCYLD;pnr-Gal4/+) under the control of thepnrpromoter produces a small-scutellumphenotype (arrow in T). Thepnr>dCYLDphenotype is fully
suppressed by an RNAi of dTRAF2 (W,UAS-dCYLD; pnr-Gal4/UAS-dTRAF2-IR) or dTAK1 (X,UAS-dCYLD; pnr-Gal4/UAS-dTAK1-IR), but not by one
of wgn (V, UAS-dCYLD; pnr-Gal4/UAS-wgn-IR).tal Cell 13, 446–454, September 2007 ª2007 Elsevier Inc. 451
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dCYLD Regulates JNK Signalingclosure during embryogenesis and metamorphosis
(Fernandez et al., 2000; Tateno et al., 2000). However,
null mutants for egr and dCYLD are fully viable and do
not display the epidermal closure defect (Igaki et al.,
2002; Moreno et al., 2002) (data not shown), implying
that Shark and Src42A act in parallel to Egr and dCYLD
in modulating JNK signaling. Consistent with this inter-
pretation, loss of shark or src42A failed to suppress the
GMR > Egr or pnr > dCYLD phenotype (data not shown).
In addition, we found that loss of the transcription factor
dFOXO could suppress both GMR > Egr and pnr >
dCYLD phenotypes (data not shown), which suggests
that dFOXO acts downstream of dCYLD in JNK signal-
ing. Consistent with this observation, dFOXO is required
downstream of JNK in modulating cell death, oxidative
stress resistance, and lifespan (Luo et al., 2007; Wang
et al., 2005).
dCYLD Deubiquitinates and Stabilizes dTRAF2
Overexpression of CYLD inmammalian tissue culture cells
negatively regulates NF-kB signaling by deubiquitinating
TRAF2/6 (Brummelkamp et al., 2003; Kovalenko et al.,
2003; Trompouki et al., 2003). dCYLD, like its mammalian
counterpart, contains two UCH deubiquitinating domains
(Bignell et al., 2000) (Figure 2A). Indeed, as described
above, our genetic analysis revealed that the UCH deubi-
quitinating domains are crucial for the in vivo functions of
dCYLD (Figures 1D and 1E, and Figure 2J). Furthermore,
our genetic epistasis data show that dCYLD acts up-
stream of dTRAF2 in the JNK pathway. Thus, we hypoth-
esized that dCYLD might act in the JNK pathway to
deubiquitinate and subsequently stabilize dTRAF2 by
preventing its ubiquitination-mediated proteolytic degra-
dation. To examine this hypothesis in vivo, a FLAG-tagged
dTRAF2 transgene (GMR > FLAG-dTRAF2) was intro-
duced into dCYLD mutants and transgenic flies. Proteins
were extracted from the heads of these flies for biochem-
ical analyses. We found that loss of dCYLD resulted in
a significant reduction in dTRAF2 protein level, while the
ubiquitination of dTRAF2 was markedly enhanced
(Figure 4A and Figure S6, lanes 2 and 3). Both changes
were suppressed by dCYLDRes (Figure 4A and Figure S6,
lane 4). Consistently, overexpression of dCYLD, but not
dCYLDDUCH, increased dTRAF2 protein level and de-
creased its ubiquitination (Figure 4A and Figure S6, lanes
5 and 6). These results show that dCYLD functions as
a deubiquitinating enzyme that deubiquitinates dTRAF2
and promotes dTRAF2 accumulation in vivo.
Polyubiquitination chains are usually formed on two
lysine residues, K48 and K63. It is generally believed that
the K48-linked polyubiquitination mediates proteasome-
dependent protein degradation (Chau et al., 1989), while
the K63-linked polyubiquitination mediates endocytosis
and signal transduction (Mukhopadhyay and Riezman,
2007). Previous work inmammalian culture cells has impli-
cated that CYLD encodes a deubiquitinating enzyme that
preferentially cleaves K63-linked polyubiquitin chain from
its target proteins for NF-kB signaling (Brummelkamp
et al., 2003; Kovalenko et al., 2003; Trompouki et al.,452 Developmental Cell 13, 446–454, September 2007 ª2007 E2003). However, a recent in vivo study in Cyld/ mice
has reported that CYLD could regulate the stability of its
target protein by effectively removing K48-linked polyubi-
quitin chain in thymocytes (Reiley et al., 2006). Interest-
ingly, JNK activity also diminished in Cyld/ thymocytes
(Reiley et al., 2006). Thus, the role of CYLD in regulating
protein stability and positively modulating JNK signaling
could be conserved in mammals.
Conclusions
CYLD mutations in human patients cause dramatic skin
tumors. However, the physiological function of CYLD
Figure 4. dCYLD Deubiquitinates and Stabilizes dTRAF2
(A) The expression (middle) and polyubiquitination (top) of Flag-
dTRAF2 driven by no copies (lane 1, dCYLDmr4 pLX107/+) or one
copy (lanes 2–6) of GMR-Gal4. Compared with heterozygous control
(lane 2, dCYLDmr4 pLX107/+; GMR-Gal4 UAS-Flag-dTRAF2/+), loss
of dCYLD results in decreased dTRAF2 protein level and increased
dTRAF2 polyubiquitination (lane 3, dCYLDmr4 pLX107; GMR-Gal4
UAS-Flag-dTRAF2/+), both of which are rescued by dCYLDRes (lane
4, dCYLDmr4 pLX107; GMR-Gal4 UAS-Flag-dTRAF2/dCYLDRes).
Overexpression of dCYLD (lane 5, dCYLDmr4 pLX107/+; GMR-Gal4
UAS-Flag-dTRAF2/UAS-dCYLD), but not dCYLDDUCH (lane 6,
dCYLDmr4 pLX107/+; GMR-Gal4 UAS-Flag-dTRAF2/UAS-dCYLD-
DUCH), leads to enriched dTRAF2 protein level and diminished
dTRAF2 polyubiquitination. b-tubulin was used as a loading control
(bottom). Data are representative of four independent experiments. A
statistic analysis of quantified dTRAF2 protein level and its ubiquitina-
tion is shown in Figure S4.
(B) A model for the roles of dCYLD and dTRAF2 in the Egr-JNK signal-
ing pathway (see text).lsevier Inc.
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tumorigenesis remain largely unknown. By generating the
null dCYLD mutation and dCYLD transgenic animals and
performing genetic analysis, we show that dCYLD is a crit-
ical regulatory component of the JNK signaling pathway.
Our genetic epistasis and biochemical analysis further
reveal that dCYLD modulates JNK signaling by deubiqui-
tinating dTRAF2 and thus preventing dTRAF2 from ubiqui-
tination-mediated proteolytic degradation. Loss of dCYLD
results in augmented ubiquitination and degradation of
dTRAF2, which renders cells resistant to apoptosis trig-
gered by JNK signaling. Deregulation of apoptosis has
been implicated as a major cause of tumorigenesis
(Thompson, 1995). Consistently, mice deficient for both
jnk1 and jnk2 were resistant to apoptosis induced by UV
irradiation, anisomycin, and MMS (Tournier et al., 2000),
and jnk1/mice exhibited enhanced skin tumor develop-
ment (She et al., 2002), a phenotype that is pathogenically
similar to cylindromatosis in CYLD human patients. To-
gether these data argue that modulation of JNK signaling
could be a conservedmechanism underlying familial cylin-
dromatosis in CYLD patients.
EXPERIMENTAL PROCEDURES
Plasmid Construction
pLX107 and dCYLDRes were produced by cloning the 6.2 kb BglII
fragment and 5.9 kb KpnI fragment from cosmid clone 41-F12 into
the BamHI and KpnI sites of pW8 vector, respectively. UAS-dCYLD
was generated by inserting the 2.1 kb XhoI-EcoRV fragment from
the EST clone SD04636 into the pUAST vector. dCYLDDCAP,
dCYLDDUCH, and dCYLDDZF were amplified by PCR, sequenced,
and inserted into pUAST vector.
Drosophila Strains
Drosophila strains used include: GMR-Gal4, UAS-Egr (Igaki et al.,
2002), l(2)08774 (Spradling et al., 1999), DTRAF1ex and DTRAF2ex
(Cha et al., 2003), pucE69 (Fanto et al., 2000), hep1 (Glise et al., 1995),
bsk1 (Riesgo-Escovar et al., 1996), sev-Gla4, UAS-dTAK1 (Mihaly
et al., 2001), UAS-Wgn-IR (Kanda et al., 2002), UAS-dTAK1-IR (Leulier
et al., 2002),UAS-Hep-IR (Ishimaru et al., 2004),UAS-dTRAF1-IR, and
UAS-dTRAF2-IR (Igaki et al., 2006).
pLX107, dCYLDRes, UAS-dCYLD, UAS-dCYLDDCAP, UAS-
dCYLDDUCH, UAS-dCYLDDZF, and UAS-Flag-dTRAF2 transgenic
flies were generated by standard P element-mediated transformation.
More than five independent lines were produced and examined for
each transgene and gene expression was verified by RT-PCR.
dCYLDmr4 mutants were generated by male recombination (Chen
et al., 1998) using the P element l(2)08774 (Spradling et al., 1999).
Genomic DNA from a total of 13 recombinants was PCR amplified
and sequenced to determine the molecular lesions. Primers used for
PCR were OLX4 (50-GTAGCAGGTCGGAACAGATTC-30) and PLAC1
(50-CACCCAAGGCTCTGCTCCCACAAT-30). dCYLDmr4 mutants pro-
duced a 0.5 kb PCR product instead of the 5.5 kb fragment generated
from the original stock.
Lifespan, Oxidative Stress Resistance,
and Dry Starvation Assay
Lifespan, oxidative stress resistance, and dry starvation were moni-
tored at 25C as described (Wang et al., 2003).
Western Blot
Heads were cut from newly eclosed flies (0–12 hr) and homogenized in
lysis buffer (Kuranaga et al., 2002). Western blots were performed asDevelopmendescribed (Kuranaga et al., 2002). In brief, lysates were separated on
10% SDS-PAGE gels and transferred to nitrocellulose membranes.
After blocking with 5% milk, the membranes were incubated with
monoclonal antibodies against FLAG (Sigma) or tubulin (Chemicon),
and then done so with a secondary HRP-conjugated anti-mouse IgG
(Jackson). Signals were detected with ECL-plus kit (PerkinElmer).
Immunoprecipitation Assay
Fly head lysates were incubated with anti-Flag M2 affinity gel (Sigma)
on ice for 1 hr. The immunoprecipitates were washed five times with
lysis buffer, separated by 10%SDS-PAGE gels, transferred to nitrocel-
lulose membranes, immunoblotted with antibody against ubiquitin
(Invitrogen), and detected as described above.
Supplemental Data
The Supplemental Data for this article, which include six figures and
their accompanying legends, can be found online at http://www.
developmentalcell.com/cgi/content/full/13/3/446/DC1/.
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